Pain Med
January 2022
Objective: To compare pain outcome reports of patients undergoing hip or knee replacement who received single-injection nerve/plexus blocks with plain bupivacaine (BPV) with those of patients who received injections of buprenorphine-clonidine-dexamethasone (BCD) admixed with BPV.
Design: Prospective, parallel-arm, randomized, double-blind trial.
Setting: A single veterans' hospital.